Twist Bioscience (TWST) Gross Margin (2017 - 2025)
Twist Bioscience (TWST) has disclosed Gross Margin for 6 consecutive years, with 34.35% as the latest value for Q2 2023.
- On a quarterly basis, Gross Margin fell 1045.0% to 34.35% in Q2 2023 year-over-year; TTM through Jun 2023 was 38.62%, a 154.0% decrease, with the full-year FY2022 number at 41.38%, up 230.0% from a year prior.
- Gross Margin was 34.35% for Q2 2023 at Twist Bioscience, up from 30.76% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 45.8% in Q3 2020 to a low of 13.04% in Q1 2019.
- A 5-year average of 33.22% and a median of 35.56% in 2020 define the central range for Gross Margin.
- Peak YoY movement for Gross Margin: surged 2945bps in 2019, then tumbled -1045bps in 2023.
- Twist Bioscience's Gross Margin stood at 19.65% in 2019, then soared by 81bps to 35.51% in 2020, then grew by 0bps to 35.61% in 2021, then grew by 28bps to 45.72% in 2022, then decreased by -25bps to 34.35% in 2023.
- Per Business Quant, the three most recent readings for TWST's Gross Margin are 34.35% (Q2 2023), 30.76% (Q1 2023), and 45.72% (Q4 2022).